Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide vs Hydroxyurea in Beta-Thalassemia
NCT06239389Phase 2Completed
- Sponsor
- National Institute of Blood and Marrow Transplant
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in beta thalassemia, sponsored by National Institute of Blood and Marrow Transplant. Started Sep 2021; status: completed.
02
Drugs
thalidomide
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT06239389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06239389.